Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV)

Journal of Vascular Surgery

Volumn 46, Issue 2, 2007, Pages 280-288

  Neufang, Achim ^a   Espinola Klein, Christine ^a   Dorweiler, Bernhard ^a   Messow, Claudia Martina ^a   Schmiedt, Walther ^a   Vahl, Christian Friedrich ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTARALDEHYDE;

ADULT; AGED; ANEURYSM; ANTICOAGULANT THERAPY; ARTICLE; CEREBROVASCULAR ACCIDENT; CLAUDICATION; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DYSLIPIDEMIA; FEMALE; FEMOROPOPLITEAL BYPASS; FOLLOW UP; GRAFT PATENCY; GRAFT SALVAGE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; KIDNEY FAILURE; LIMB ISCHEMIA; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POPLITEAL ARTERY; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; RISK FACTOR; SAPHENOUS VEIN; SMOKING; SURGICAL TECHNIQUE; UMBILICAL VEIN; VEIN PROSTHESIS;

AGED; AGED, 80 AND OVER; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; FEMORAL ARTERY; FIXATIVES; FOLLOW-UP STUDIES; GLUTARAL; GRAFT OCCLUSION, VASCULAR; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LIMB SALVAGE; LOWER EXTREMITY; MALE; MIDDLE AGED; POPLITEAL ARTERY; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THROMBOSIS; TIME FACTORS; TISSUE FIXATION; TREATMENT OUTCOME; UMBILICAL VEINS; VASCULAR PATENCY;

EID: 34547121732     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.03.054     Document Type: Article

References (41)

1. Dardik H.D., Ibrahim I.M., Sprayregen S., and Dardik I.I. Clinical experience with modified human umbilical cord vein for arterial bypass. Surgery 79 (1976) 618-624
2. Dardik H., Ibrahim I.M., and Dardik I. Evaluation of glutaraldehyde-tanned human umbilical cord vein as a vascular prosthesis for bypass to the popliteal, tibial, and peroneal arteries. Surgery 83 (1978) 577-588
3. Eickhoff J.H., Buchardt Hansen H.J., Bromme A., Ericsson B.F., Kordt K.F., Mouritzen C., et al. A randomized clinical trial of PTFE versus human umbilical vein for femoropopliteal bypass surgery. Preliminary results. Br J Surg 70 (1983) 85-88
4. Buth J., Cohen R.F., and Adhin S.K. The selective use of modified human umbilical vein as an arterial substitute in the lower extremity. Surg Gynecol Obstet 157 (1983) 523-529
5. Boontje A.H. The biograft for femoropopliteal bypass. J Cardiovasc Surg 24 (1983) 497-502 (Torino)
6. Haun W.E., Brantigan C.O., and Sawyer R.B. Intimal breakdown causing failure of human umbilical vein graft. Arch Surg 116 (1981) 230-231
7. Roedersheimer L.R., Feins R.H., Schwartz S.I., DeWeese J.A., and Green R.M. Comparison of platelet adherence and aggregation in modified human umbilical vein and autogenous vein grafts. Am J Surg 140 (1980) 591-595
8. Giordano J.M., and Keshishian J.M. Aneurysm formation in human umbilical vein grafts. Surgery 91 (1982) 343-345
9. Layer G.T., King R.B., and Jamieson C.W. Early aneurysmal degeneration of human umbilical vein bypass grafts. Br J Surg 71 (1984) 709-710
10. Boontje A.H. Aneurysm formation in human umbilical vein grafts used as arterial substitutes. J Vasc Surg 2 (1985) 524-529
11. Aalders G.J., van Vroonhoven T.J., Lobach H.J., and Wijffels C.C. PTFE versus human umbilical vein in above knee femoropopliteal bypass. Early results of a randomized clinical trial. J Cardiovasc Surg 29 (1988) 186-190 (Torino)
12. Aalders G.J., and van Vroonhoven T.J. Polytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: six-year results of a randomized clinical trial. J Vasc Surg 16 (1992) 816-823
13. Rutherford R.B., Baker J.D., Ernst C., Johnston K.W., Porter J.M., Ahn S., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997) 517-538
14. Klinkert P., Post P.N., Breslau P.J., and van Bockel J.H. Saphenous vein versus PTFE for above knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 27 (2004) 357-362
15. Donaldson M.C., Whittemore A.D., and Mannick J.A. Further experience with an all-autogenous tissue policy for infrainguinal reconstruction. J Vasc Surg 18 (1993) 41-48
16. Gentile A.T., Lee R.W., Moneta G.L., Taylor L.M., Edwards J.M., and Porter J.M. Results of bypass to the popliteal and tibial arteries with alternative sources of autogenous vein. J Vasc Surg 23 (1996) 272-279
17. Aune S., and Laxdal E. Above-knee prosthetic femoropopliteal bypass for intermittent claudication. Results of the initial and secondary procedures. Eur J Vasc Endovasc Surg 19 (2000) 476-480
18. Johnson W.C., and Lee K.K. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 32 (2000) 268-277
19. Aalders G.J., and van Vroonhoven T.J. Polytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: six-year results of a randomized clinical trial. J Vasc Surg 16 (1992) 816-823
20. Dardik H., Wengerter K., Qin F., Pangilinan A., Silvestri F., Wolodiger F., et al. Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases. J Vasc Surg 35 (2002) 64-71
21. Strobel R., Boontje A.H., and Van Den Dungen J.J. Aneurysm formation in modified human umbilical vein grafts. Eur J Vasc Endovasc Surg 11 (1996) 417-420
22. Sogaro F., Galeazzi E., Amroch D., and Ganassin L. Pantaloon vein graft technique in tibial revascularization with arteriovenous fistula for limb salvage. Cardiovasc Surg 4 (1996) 377-380
23. McCollum C., Kenchington G., Alexander C., Franks P.J., and Greenhalgh R.M. PTFE or HUV for femoro-popliteal bypass: a multi-centre trial. Eur J Vasc Surg 5 (1991) 435-443
24. Eickhoff J.H., Broome A., Ericsson B.F., Buchardt Hansen H.J., Kordt K.F., Mouritzen C., et al. Four-year results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal bypass. J Vasc Surg 6 (1987) 506-511
25. Dardik H., Miller N., Dardik A., Ibrahim I., Sussman B., Berry S.M., et al. A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb. J Vasc Surg 7 (1988) 336-346
26. McLoughlin R., O'Leary G., Fitzgerald L.P., and O'Donnell J.A. The effect of distal anastomotic site on PTFE graft patency in lower extremity bypass. Eur J Vasc Surg 3 (1989) 417-419
27. Raptis S., and Miller J.H. Influence of a vein cuff on polytetrafluoroethylene grafts for primary femoropopliteal bypass. Br J Surg 82 (1995) 487-491
28. Griffiths G.D., Nagy J., Black D., and Stonebridge P.A. Randomized clinical trial of distal anastomotic interposition vein cuff in infrainguinal polytetrafluoroethylene bypass grafting. Br J Surg 91 (2004) 560-562
29. Deutsch M., Meinhart J., Fischlein T., Preiss P., and Zilla P. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. Surgery 126 (1999) 847-855
30. Bosiers M., Deloose K., Verbist J., Schroe H., Lauwers G., Lansink W., et al. Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results. J Vasc Surg 43 (2006) 313-318
31. Walluscheck K.P., Bierkandt S., Brandt M., and Cremer J. Infrainguinal ePTFE vascular graft with bioactive surface heparin bonding. First clinical results. J Cardiovasc Surg 46 (2005) 425-430 (Torino)
32. Treiman G.S., Treiman R., and Whiting J. Results of percutaneous subintimal angioplasty using routine stenting. J Vasc Surg 43 (2006) 513-519
33. Aarts F., Blankensteijn J.D., van der Vliet J.A., and Kool L.J. Subintimal angioplasty of supra- and infrageniculate arteries. Ann Vasc Surg 20 (2006) 620-624
34. Abahji T.N., Tato F., Rieger J., Offner A., Will S., Hoelscher G., et al. Stenting of the superficial femoral artery after suboptimal balloon angioplasty: one-year results. Int Angiol 25 (2006) 184-189
35. Solis E., Hollier L.H., Plate G., Dewanjee M.K., and Kaye M.P. Early and late comparison of umbilical vein and PTFE grafts in control and piroxicam-treated dogs. Int Angiol 5 (1986) 73-78
36. Berglund J., Bjorck M., and Elfstrom J. Long-term results of above knee femoro-popliteal bypass depend on indication for surgery and graft-material. Eur J Vasc Endovasc Surg 29 (2005) 412-418
37. Dardik H., Ibrahim I.M., Sussman B., Kahn M., Sanchez M., Klausner S., et al. Biodegradation and aneurysm formation in umbilical vein grafts. Observations and a realistic strategy. Ann Surg 199 (1984) 61-68
38. Hasson J.E., Newton W.D., Waltman A.C., Fallon J.T., Brewster D.C., Darling R.C., et al. Mural degeneration in the glutaraldehyde-tanned umbilical vein graft: incidence and implications. J Vasc Surg 4 (1986) 243-250
39. Boontje A.H. Angiographic assessment of biografts for femoropopliteal bypass. J Cardiovasc Surg 27 (1986) 136-140 (Torino)
40. Karkow W.S., Cranley J.J., Cranley R.D., Hafner C.D., and Ruoff B.A. Extended study of aneurysm formation in umbilical vein grafts. J Vasc Surg 4 (1986) 486-492
41. Sommeling C.A., Buth J., and Jakimowicz J.J. Long-term behavior of modified human umbilical vein grafts; late aneurysmal degeneration established by color-duplex scanning. Eur J Vasc Surg 4 (1990) 89-94